Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Venous Thromboembolism 8Thrombocythemia, Essential 2Primary Myelofibrosis 2Polycythemia Vera 2Neoplasms 2Thrombosis 1Thrombocytopenia 1Testicular Neoplasms 1Sarcoma 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Myocardial Infarction 1Myeloproliferative Disorders 1Multiple Myeloma 1Hemorrhage 1Hematoma 1Hematologic Diseases 1Glioblastoma 1Bone Neoplasms 1Acute Coronary Syndrome 1

Interventions

Enoxaparin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematoma × Aspirin × Classical hematology × Clear all
NCT03244020 2025-10-03

LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology

Massachusetts General Hospital

Phase 4 Enrolling by invitation
2,868 enrolled
Classical hematologySarcoma

Bone Neoplasms, Hematoma, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡